Table 1.
Priming peptide | ± TGF/β1 | Triple | Double | IL−2+, IFN-γ+ | IL−2+, TNF-α+ | IFN-γ+, TNF-α+ | Single | IL−2+ | IFN-γ+ | TNF-α+ | No cytokines | Cumulative |
||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
IL−2+ | TFN-γ+ | TNF-α+ | ||||||||||||
OVA | − | 33.98 | 29.29 | 27.02 | 2.27 | 0.00 | 26.58 | 26.34 | 0.18 | 0.06 | 10.24 | 89.61 | 36.31 | 61.18 |
+ | 35.28 | 28.59 | 24.12 | 4.35 | 0.13 | 24.51 | 24.25 | 0.26 | 0.00 | 11.60 | 88.00 | 39.76 | 59.79 | |
Y3 | − | 46.99 | 21.14 | 17.91 | 3.14 | 0.09 | 19.73 | 19.46 | 0.27 | 0.00 | 12.10 | 87.50 | 50.22 | 65.26 |
+ | 36.38 | 17.63 | 12.92 | 4.47 | 0.24 | 22.01 | 21.83 | 0.12 | 0.06 | 24.05 | 75.60 | 41.15 | 49.66 | |
Q4 | − | 51.03 | 14.45 | 11.97 | 2.48 | 0.00 | 20.74 | 20.52 | 0.18 | 0.05 | 13.76 | 86.00 | 53.56 | 63.18 |
+ | 35.66 | 14.11 | 9.94 | 3.90 | 0.26 | 19.00 | 18.80 | 0.17 | 0.03 | 31.27 | 68.30 | 39.86 | 46.03 | |
T4 | − | 59.10 | 10.52 | 6.17 | 4.07 | 0.28 | 12.45 | 12.03 | 0.28 | 0.14 | 17.86 | 81.37 | 63.59 | 65.83 |
+ | 33.56 | 9.94 | 5.24 | 4.38 | 0.32 | 14.22 | 13.72 | 0.40 | 0.11 | 42.27 | 56.90 | 38.37 | 39.52 | |
V4 | − | 67.47 | 7.26 | 3.93 | 2.62 | 0.71 | 5.95 | 5.55 | 0.20 | 0.20 | 19.31 | 79.58 | 71.01 | 72.32 |
24.67 | 8.19 | 2.54 | 5.22 | 0.44 | 17.69 | 17.58 | 0.07 | 0.04 | 49.45 | 50.01 | 30.37 | 27.72 |
OT-I splenocytes were primed and restimulated as shown in Fig. 1. The percentages of the resulting effector CD8+ T cells producing a particular set of cytokines or all of those producing an individual cytokine (Cumulative) are shown. Data shown are representative of at least three individual experiments with similar results